chemotherapy

DEFINITION of chemotherapy

The term chemotherapy refers to the systemic administration of antineoplastic (anti-cancer) drugs designed to destroy, shrink, or slow the proliferation of malignant neoplasms. Because these chemicals primarily target rapidly dividing cells, they often affect healthy tissues with high turnover rates (such as hair follicles, bone marrow, and the gastrointestinal lining), leading to characteristic side effects like alopecia, neutropenia, and nausea. Chemotherapy can be administered with curative intent, as neoadjuvant therapy (before surgery to shrink a tumor), adjuvant therapy (after surgery to eliminate microscopic disease), or as palliative care to relieve symptoms in advanced cancer.

---

ETYMOLOGY of chemotherapy

greek german

Component	Origin	Meaning
chem- / chemo-	Greek khemeia (χημεία) via German Chemie	”Alchemy” or “chemical”
-therapy	Greek therapeia (θεραπεία)	“Healing” or “medical treatment”

The term was coined in the early 1900s by German immunologist Paul Ehrlich (originally as Chemotherapie) to describe the use of specific chemicals to treat infectious diseases (like syphilis), but the word evolved in the mid-20th century to be almost exclusively associated with cancer treatment.

---

🔀 ALIASES / ALTERNATE TERMS

• Chemo (common colloquial abbreviation)
• Antineoplastic therapy
• Cytotoxic therapy
• Medical oncology treatment
• Systemic therapy (when distinguished from local treatments like surgery/radiation)

---

🔗 RELATED TERMS

• neoplasm / carcinoma — an abnormal, often malignant growth of tissue targeted by chemotherapy.
• Adjuvant therapy — chemotherapy given after primary treatment (like surgery) to lower the risk of recurrence.
• Neoadjuvant therapy — chemotherapy given before primary treatment to shrink a tumor.
• Immunotherapy — biological treatments that stimulate the patient’s immune system to attack cancer cells (distinct from cytotoxic chemotherapy).
• Alopecia — hair loss, a frequent and visible side effect of chemotherapy.
• Pancytopenia — a dangerous reduction in red cells, white cells, and platelets due to bone marrow suppression by cytotoxic drugs.
• Extravasation — the accidental leakage of intravenous chemotherapy drugs into surrounding tissue, potentially causing severe necrosis.

---

CODING CORNER

🏥 ICD-10-CM CODES

Encounters for Treatment

Code	Description
Z51.11	Encounter for antineoplastic chemotherapy
Z51.12	Encounter for antineoplastic immunotherapy
Z51.89	Encounter for other specified aftercare (often used for targeted therapy non-antineoplastic)

Adverse Effects & Complications (7th character required for T-codes)

Code	Description
T45.1X5A	Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter
T45.1X5D	Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter
T80.810A	Extravasation of vesicant antineoplastic medication, initial encounter
D70.1	Agranulocytosis secondary to cancer chemotherapy
E86.0	Dehydration (common consequence of chemo-induced nausea/vomiting)

---

🔧 COMMON CPT CODES (Chemotherapy Administration)

CPT Code	Description
96401	Chemotherapy administration, subcutaneous or intramuscular; non-hormonal anti-neoplastic
96409	Chemotherapy administration; intravenous, push technique, single or initial substance/drug
96413	Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415	Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)
96420	Chemotherapy administration, intra-arterial; push technique
96523	Irrigation of implanted venous access device for drug delivery systems
36593	Declotting by thrombolytic agent of implanted vascular access device or catheter

---

⚠️ Coding Note: Sequencing is paramount when coding chemotherapy encounters. If the patient’s primary reason for the visit is to receive chemotherapy, Z51.11 (Encounter for antineoplastic chemotherapy) must be listed as the principal/first-listed diagnosis, followed immediately by the active malignancy code (e.g., C50.911).

For CPT coding, administration of highly complex, cytotoxic antineoplastic agents falls under the 964XX series. Coders must distinguish these from non-chemotherapy therapeutic/prophylactic infusions (96365-96379), even if given during the same encounter (such as an anti-emetic given prior to the chemo). Time documentation (start and stop times) is strictly required to bill infusion codes like 96413 and 96415.

---

DERIVATIONS of chemotherapy

TABLE definition AS Definition
FROM #medterm 
WHERE length(filter(roots, (word) => econtains([[]].roots, word))) > 0 AND file.name != [[]].file.name
SORT file.name ASC

---

Query functionality

TABLE definition AS Definition
FROM #medterm 
WHERE length(filter(definition, (word) => econtains([[]].definition, word))) > 0 AND file.name != [[]].file.name

Med roots Appendix A Prefixes Appendix B Combining Forms Appendix C Suffixes Appendix D Suffix forms